Evaluation of the lactulose/mannitol and 51Cr- ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Influence of urinary volume, sex, age, smoking, and intestinal disease on marker excretion

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 8, 1997, Pages 805-812

  Blomquist, L ^a   Bark, T ^a   Hedenborg, G ^a   Norman, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

14C mannitol; 51Cr Ethylenediaminetetraacetic acid; Intestinal absorption; Intestinal permeability; Lactulose; Mannitol

Indexed keywords

BIOLOGICAL MARKER; EDETATE CHROMIUM CR 51; LACTULOSE; MANNITOL;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; ENTEROPATHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINE VOLUME;

EID: 0030786894     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529708996538     Document Type: Article

References (37)

1. 14C-mannitol methods for intestinal permeability. Frequency distribution pattern and variability of markers and marker ratios in healthy subjects. Scand J Gastroenterol 1993;28:274-80.
2. Menzies IS. Transmucosal passage of inert molecules in health and disease. In: Skadhauge E, Heintze K, editors. Intestinal absorption and secretion. Falk symposium 36. Lancaster: MTP Press Ltd, 1984. p. 527-43.
3. 51Cr-labelled ethylenediaminetetraacetate, L-rhamnose and polyethyleneglycol 400 as probe markers for assessment in vivo of human intestinal permeability. Clin Sci 1986;71:71-80.
4. Bjarnason I, Peters TJ, Levi AJ. Intestinal permeability: clinical correlates. Dig Dis 1986;4:83-92.
5. Bjarnason I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984;1: 179-82.
6. Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ. Effect of non-steroidal antiinflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986;27: 1292-7.
7. Oman H, Henriksson K, Blomquist L, Johansson SGO. Increased intestinal permeability to polysucrose in NSAID-treated patients. Eur J Gastroenterol Hepatol 1992;4:235-40.
8. Behrens RH, Szaz KF, Northrop C, Elia M, Neale G. Radionucleide tests for the assessment of intestinal permeability. Eur J Clin Invest 1987;17:100-5.
9. Juby LD, Rothwell J, Axon ATR. Lactulose/mannitol test: an ideal screen for celiac disease. Gastroenterology 1989;96:79-85.
10. Katz KD, Hollander D, Vadheim CM, McElree C, Delahunty T, Dadufalza VD et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989;97:927-31.
11. Ukabam SO, Clamp JR, Cooper BT. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion 1983;27:70-4.
12. Katz KD, Hollander D. Intestinal mucosal permeability and rheumatological diseases. Baillieres Clin Rheumatol 1989;3: 271-84.
13. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 1986;105:883-5.
14. Ma TY, Hollander D, Krugliak P, Katz K. PEG 400, a hydrophilic molecule probe for measuring intestinal permeability. Gastroenterology 1990;98:39-46.
15. Ukabam SO, Cooper BT. Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease. Dig Dis Sci 1984;29:809-16.
16. Iqbal TH, Lewis KO, Cooper BT. Diffusion of polyetylene glycol-400 across lipid barriers in vitro. Clin Sci 1993;85:111-5.
17. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992;27:721-6.
18. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
19. Öman H, Henriksson K, Johansson SGO, Blomquist L. Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardized meal but not by forming marker ratios. Scand J Gastroenterol 1996;31:1182-8.
20. Catassi C, Fabiani E, Ratsch IM, Bonucci A, Dotti M, Coppa GV, et al. Is the sugar intestinal permeability test a reliable investigation for coeliac disease screening? Gut 1997;40:215-7.
21. 51Cr-labelled ethylenediaminetetraacetate as markers of intestinal permeability in man. Clin Sci 1987;73:197-204.
22. 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change. Scand J Gastroenterol 1992;27: 769-73.
23. 14C-mannitol as markers of intestinal permeability in man. Scand J Gastroenterol 1995;30:1172-7.
24. 51Cr-labelled ethylene diamine tetra-aceate test in inflammatory bowel disease. Hepatogastroenterology 1990;37 Suppl 11:113-7.
25. 51Cr-Ethylenediaminetetraacetic acid absorption test. Methodological aspects. Scand J Gastroenterol 1989;24: 351-8.
26. Davies NM, Wright MR, Jamali F. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model. Pharm Res 1994;11:1652-6.
27. Blomquist L, Öman H, Henriksson K, Johansson SGO. Increased absorption of polysucrose, a marker of intestinal paracellular permeability, in Crohn's disease. Eur J Gastroenterol Hepatol 1993;5:913-7.
28. Bijlsma PB, Peeters RA, Groot JA, Dekker PR, Taminiau JAJM, van der Meer R. Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis. Gastroenterology 1995;108:687-96.
29. Saweirs WM, Andrews DJ, Low-Beer TS. The double sugar test of intestinal permeability in the elderly. Age Ageing 1985;14: 312-5.
30. Saltzman JR, Kowdley KV, Perrone G, Russel RM. Changes in small-intestine permeability with aging. J Am Geriatr Soc 1995; 43:160-4.
31. Peeters M, Hiele M, Ghoos Y, Hyusmans V, Geboes K, Vantrappen G, et al. Test conditions greatly influence permeation of water soluble molecules through intestinal mucosa: need for standardisation. Gut 1994;35:140-4-8.
32. 51Cr-labelled ethylenediaminetetraacetic acid in healthy subjects. Scand J Gastroenterol 1996;31: 254-9.
33. Prytz H, Benoni C, Tagesson C. Does smoking tighten the gut? Scand J Gastroenterol 1989;24:1084-8.
34. Söderholm J, Olaison G, Sjödahl R, Tagesson C. Smoking and intestinal absorption of polyethylene glycols in Crohn's disease. Scand J Gastroenterol 1993;28:163-7.
35. Laker MF, Bull HJ, Menzies IS. Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man. Eur J Clin Invest 1982;12:485-91.
36. Blau K. Increased mannitol excretion in controlled hereditary galactosemia. Clin Chim Acta 1972;38:441-5.
37. Ng WG, Donnell GN, Berggren WR. Mannitol excretion in galactosemia patients. Clin Chim Acta 1975;64:39-44.